Connect your AI

CryoPort, Inc. CYRX Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

Charles River LaboratoriesCRL

$5.2M+528%

Other financials

Income statement

Revenue$47.8M+16.5%

Gross profit$21.9M+17.6%

Operating income-$9.6M-33.6%

Net income-$10.5M+12.0%

EPS (diluted)-$0.25+10.7%

Balance sheet

Cash & equivalents$272.9M+656%

Total debt$230.7M+293%

Total equity$495.0M+24.1%

Total assets$763.6M+9.1%

Cash flow

Operating cash flow$3.7M+186%

CapEx$10.0M+215%

Free cash flow-$6.2M+16.8%

Valuation

Market cap$800.39M+151%

Enterprise value$758.23M+122%

P/E10.6×—

P/S4.4×+2.4×

Profitability

Gross margin47.2%+1.6pp

Operating margin-21.4%-8.8pp

Net margin39.2%+22.1pp

FCF margin-13%-3.6pp

Returns & leverage

Return on equity14.5%+8.6pp

Debt / equity0.5×+0.3×

Current ratio2.1×-3.5×

Where this comes from

Reported directly by CryoPort, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: CryoPort, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CryoPort, Inc.'s increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CryoPort, Inc.'s increase (decrease) in contract liabilities and current deferred income?: CryoPort, Inc. (CYRX) reported increase (decrease) in contract liabilities and current deferred income of $1.38M in Q1 2026.
How has CryoPort, Inc.'s increase (decrease) in contract liabilities and current deferred income changed year-over-year?: CryoPort, Inc.'s increase (decrease) in contract liabilities and current deferred income increased by 97.3% year-over-year, from $699K to $1.38M.